Acorda Therapeutics (ACOR) is out with findings from a study assessing a Diazepam nasal spray in...

|About: Acorda Therapeutics, Inc. (ACOR)|By:, SA News Editor

Acorda Therapeutics (ACOR) is out with findings from a study assessing a Diazepam nasal spray in patients with epilepsy who experience cluster seizures. The study shows the drug is well absorbed from the nasal cavity and "had a similar pharmacokinetic profile regardless of when administered relative to the seizure episode." (PR)